Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Furman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Pharmacology|August 30, 2016
Editorial overview: Anti-infectivesPhillip Furman, Michael J Sofia
Antimicrobial Agents and Chemotherapy|October 27, 2004
In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1Katyna Borroto-Esoda, Florence Myrick, Joy Feng, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudineScott A Jones, Eisuke Murakami, William Delaney, et al.
Journal of Virology|January 5, 2002
Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracilToshiki Yamamoto, Samuel Litwin, Tianlun Zhou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Pharmacology|August 30, 2016
Editorial overview: Anti-infectivesPhillip Furman, Michael J Sofia
Antimicrobial Agents and Chemotherapy|October 27, 2004
In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1Katyna Borroto-Esoda, Florence Myrick, Joy Feng, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudineScott A Jones, Eisuke Murakami, William Delaney, et al.
Journal of Virology|January 5, 2002
Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracilToshiki Yamamoto, Samuel Litwin, Tianlun Zhou, et al.
Pageof 1